A Nebraska man has found relief from sickle cell anemia after undergoing gene therapy. The 20-year-old traveled to St. Louis for the treatment, which has shown promising results.

The gene therapy, called Lyfgenia, was approved by the Food and Drug Administration in late 2023. It has helped the man's body become nearly free of sickle cells. Further details about the treatment and its effects are available from the source, including information on how sickle cell anemia affects patients and the impact of the gene therapy.